Alpa Laboratories Clarifies Board Meeting Date to August 13, 2026
Alpa Laboratories Limited clarifies its Board Meeting date. The meeting is confirmed for August 13, 2026, at 3:00 PM at the registered office. A previous mention of August 14, 2026, was a typographical error.
This is a minor administrative correction regarding a meeting date and is unlikely to have any material impact on the company's operations or stock performance.
The announcement is a clarification of a previously stated date and does not contain new financial or business information that would positively or negatively impact the company's outlook.
Alpa Laboratories Limited has issued a clarification regarding the date of its upcoming Board Meeting. The company wishes to inform all stakeholders that the correct date for the Board Meeting is Thursday, August 13, 2026, scheduled to commence at 3:00 PM. This meeting will be held at the company's registered office.
The company noted that a reference to August 14, 2026, which appeared in the subject line of a previous intimation and in the XBRL upload, was a typographical error. Alpa Laboratories regrets any confusion this mistake may have caused and confirms that all official communications will reflect the accurate meeting date of August 13, 2026.
What to do with a filing like this
Alpa Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Alpa Laboratories Limited. Read the original for the full detail.